Inhibitors of PI3 kinase and / or MTOR

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein the variables are as defined herein.

Saved in:
Bibliographic Details
Main Authors NISHIMURA NOBUKO, ANDREWS KRISTIN, BOOKER SHON, CEE VICTOR J, D. ANGELO NOEL, WU BIN, SMITH ADRIAN L, LIAO HONGYU, WURZ RYAN, TAMAYO NURIA A, BO YUNXIN Y, LIU LONGBIN, YANG KEVIN, LANMAN BRIAN A, HERBERICH BRADLEY J, PETTUS LIPING H, TADESSE SEIFU, HONG FANG-TSAO, JACKSON CLAIRE L. M, NORMAN MARK H, REED ANTHONY B
Format Patent
LanguageChinese
English
Published 04.07.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein the variables are as defined herein.
Bibliography:Application Number: CN201080030184